Skip to main content

MAGNA Pharmaceuticals Partners with LSPediA for DSCSA Serialization

By August 2, 2018September 28th, 2018Company News, Customers, DSCSA, Serialization, Track and Trace

Dr. Warren P. Lesser (MAGNA Pharmaceuticals CEO), Riya Cao (LSPediA CEO)

Farmington Hills, MI – August 2, 2018 LSPediA LLC, a leading software and service provider for the pharmaceutical industry, today announced a new business relationship with MAGNA Pharmaceuticals.

MAGNA specializes in supplying high-quality prescription and consumer products to healthcare providers contracted under the U.S. Department of Veterans Affairs and the civilian market. Meeting federal and state compliance requirements is a proud tradition and a non-negotiable commitment for MAGNA. The 10-year vision of the FDA’s 2013 Drug Supply Chain Security Act enforces new and stringent requirements to strengthen the U.S. drug supply chain and eradicate drug counterfeiting.

Patient safety is paramount in our mission, in addition to providing efficacious and affordable products/services for patients and other healthcare stakeholders,” said Warren Lesser, Ph.D., CEO of MAGNA Pharmaceuticals. “Partnering with LSPediA enables DSCSA compliance and augments our supply chain operations. The cloud technology and RF mobile scanners automate our processes to quickly trade and distribute serialized products with 100% accuracy, contributing to overall healthcare delivery.

By leveraging RxChain®, MAGNA Pharmaceuticals enables Track and Trace, Serialization, shipment aggregation, and seamless data exchange with trading partners and provides full FDA DSCSA compliance now and for the future.

“Our software is built for companies like MAGNA to advance supply chain and meet compliance,” said Riya Cao, LSPediA CEO. “RxChain®’s Cloud Solution, mobile technology, and best-in-practice workflow serve as a robust serialization platform for MAGNA’s daily operations. When we take on the heavy lifting of compliance and serialization, our customers can focus on their core business and flourish.”



About MAGNA Pharmaceuticals, Inc.®

MAGNA Pharmaceuticals, Inc® is a privately-owned U.S. company based in Louisville, KY, which specializes in bringing to market high-quality, safe, and affordable pharmaceutical products and dietary supplements. Formed in 2000 with accountability as a core value, MAGNA is dedicated to patient safety and compliance with the FDA, DEA, and the Kentucky Board of Pharmacy.

Learn more about MAGNA Pharmaceuticals at


About LSPediA – Life Sciences Solutions

LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA’s serialization solution RxChain® protects pharma companies against counterfeit and regulatory risks and improves supply chain efficiency through automation, integration, and mobile computing. Pharmaceutical manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to manage serial data, serial warehouse, and serial data exchange with trading partners.

Contact (248) 973-2008, [email protected], or visit to learn more.